Related references
Note: Only part of the references are listed.Mutation screening of PALB2 in clinically ascertained families from the Breast Cancer Family Registry
Tu Nguyen-Dumont et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Eff ect of PALB2 status on breast cancer precision medicine
Suzette Delaloge et al.
LANCET ONCOLOGY (2015)
Growing recognition of the role for rare missense substitutions in breast cancer susceptibility
Sean V. Tavtigian et al.
BIOMARKERS IN MEDICINE (2014)
Comprehensive Sequencing of PALB2 in Patients With Breast Cancer Suggests PALB2 Mutations Explain a Subset of Hereditary Breast Cancer
Priscilla H. Fernandes et al.
CANCER (2014)
PALB2 sequencing in Italian familial breast cancer cases reveals a high-risk mutation recurrent in the province of Bergamo
Irene Catucci et al.
GENETICS IN MEDICINE (2014)
Low prevalence of germline PALB2 mutations in Australian triple-negative breast cancer
Michelle W. Wong-Brown et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Breast-Cancer Risk in Families with Mutations in PALB2
A. C. Antoniou et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Germline Variation in Cancer-Susceptibility Genes in a Healthy, Ancestrally Diverse Cohort: Implications for Individual Genome Sequencing
Dale L. Bodian et al.
PLOS ONE (2014)
Analysis of PALB2 Gene in BRCA1/BRCA2 Negative Spanish Hereditary Breast/Ovarian Cancer Families with Pancreatic Cancer Cases
Ana Blanco et al.
PLOS ONE (2013)
Prevalence of PALB2 Mutations in Breast Cancer Patients in Multi-Ethnic Asian Population in Malaysia and Singapore
Sze Yee Phuah et al.
PLOS ONE (2013)
Prevalence of PALB2 mutations in Australasian multiple-case breast cancer families
Zhi L. Teo et al.
BREAST CANCER RESEARCH (2013)
Detection of a large rearrangement in PALB2 in Spanish breast cancer families with male breast cancer
Ana Blanco et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Novel germline PALB2 truncating mutations in African American breast cancer patients
Yonglan Zheng et al.
CANCER (2012)
Rare occurrence of PALB2 mutations in ovarian cancer patients from the Volga-Ural region
D. Prokofyeva et al.
CLINICAL GENETICS (2012)
Germline mutations in BRIP1 and PALB2 in Jewish high cancer risk families
Irene Catucci et al.
FAMILIAL CANCER (2012)
Rare germline mutations in PALB2 and breast cancer risk: A population-based study
Marc Tischkowitz et al.
HUMAN MUTATION (2012)
Guidelines for Splicing Analysis in Molecular Diagnosis Derived from a Set of 327 Combined In Silico/In Vitro Studies on BRCA1 and BRCA2 Variants
Claude Houdayer et al.
HUMAN MUTATION (2012)
Germline mutations in PALB2 in African-American breast cancer cases
Yuan Chun Ding et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
PALB2 mutations in German and Russian patients with bilateral breast cancer
Natalia Bogdanova et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
PALB2 germline mutations in familial breast cancer cases with personal and family history of pancreatic cancer
Paolo Peterlongo et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
BRIP1, PALB2, and RAD51C mutation analysis reveals their relative importance as genetic susceptibility factors for breast cancer
Michelle W. Wong et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Contribution of Inherited Mutations in the BRCA2-Interacting Protein PALB2 to Familial Breast Cancer
Silvia Casadei et al.
CANCER RESEARCH (2011)
PALB2 mutations in familial breast and pancreatic cancer
Erin W. Hofstatter et al.
FAMILIAL CANCER (2011)
EMMA, a Cost- and Time-Effective Diagnostic Method for Simultaneous Detection of Point Mutations and Large-Scale Genomic Rearrangements: Application to BRCA1 and BRCA2 in 1,525 Patients
Virginie Caux-Moncoutier et al.
HUMAN MUTATION (2011)
Germline Mutations in the PALB2 Gene Are Population Specific and Occur with Low Frequencies in Familial Breast Cancer
Heide Hellebrand et al.
HUMAN MUTATION (2011)
Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals
Kirsi M. Kuusisto et al.
BREAST CANCER RESEARCH (2011)
A novel germline PALB2 deletion in Polish breast and ovarian cancer patients
Agnieszka Dansonka-Mieszkowska et al.
BMC MEDICAL GENETICS (2010)
Are PALB2 mutations associated with increased risk of male breast cancer?
A. Sauty de Chalon et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Evaluation of variants in the CHEK2, BRIP1 and PALB2 genes in an Irish breast cancer cohort
N. M. McInerney et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
A PALB2 germline mutation associated with hereditary breast cancer in Italy
Laura Papi et al.
FAMILIAL CANCER (2010)
PALB2: a novel inactivating mutation in a Italian breast cancer family
Cristina Balia et al.
FAMILIAL CANCER (2010)
Evaluation of the Contribution of the Three Breast Cancer Susceptibility Genes CHEK2, STK11, and PALB2 in Non-BRCA 1/2 French Canadian Families with High Risk of Breast Cancer
Frederic Guenard et al.
GENETIC TESTING AND MOLECULAR BIOMARKERS (2010)
A method and server for predicting damaging missense mutations
Ivan A. Adzhubei et al.
NATURE METHODS (2010)
A PALB2 mutation associated with high risk of breast cancer
Melissa C. Southey et al.
BREAST CANCER RESEARCH (2010)
The prevalence of PALB2 germline mutations in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives
A-Yong Cao et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Analysis of FANCB and FANCN/PALB2 Fanconi Anemia genes in BRCA1/2-negative Spanish breast cancer families
Maria J. Garcia et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
PALB2 Links BRCA1 and BRCA2 in the DNA-Damage Response
Feng Zhang et al.
CURRENT BIOLOGY (2009)
Human Splicing Finder: an online bioinformatics tool to predict splicing signals
Francois-Olivier Desmet et al.
NUCLEIC ACIDS RESEARCH (2009)
Exomic Sequencing Identifies PALB2 as a Pancreatic Cancer Susceptibility Gene
Sian Jones et al.
SCIENCE (2009)
Penetrance analysis of the PALB2 c.1592delT founder mutation
Hannele Erkko et al.
CLINICAL CANCER RESEARCH (2008)
Analysis of the gene coding for the BRCA2-interacting protein PALB2 in hereditary prostate cancer
Marc Tischkowitz et al.
PROSTATE (2008)
A recurrent mutation in PALB2 in Finnish cancer families
Hannele Erkko et al.
NATURE (2007)
Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer
Sarah Reid et al.
NATURE GENETICS (2007)
PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene
Nazneen Rahman et al.
NATURE GENETICS (2007)
Identification of a novel truncating PALB2 mutation and analysis of its contribution to early-onset breast cancer in French-Canadian women
William D. Foulkes et al.
BREAST CANCER RESEARCH (2007)
Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2
Bing Xia et al.
MOLECULAR CELL (2006)
Improving sensitivity of electrophoretic heteroduplex analysis using nucleosides as additives:: Application to the breast cancer predisposition gene BRCA2
Jérémie Weber et al.
ELECTROPHORESIS (2006)
Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral
SV Tavtigian et al.
JOURNAL OF MEDICAL GENETICS (2006)
Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals
G Yeo et al.
JOURNAL OF COMPUTATIONAL BIOLOGY (2004)
SIFT: predicting amino acid changes that affect protein function
PC Ng et al.
NUCLEIC ACIDS RESEARCH (2003)
GeneSplicer: a new computational method for splice site prediction
M Pertea et al.
NUCLEIC ACIDS RESEARCH (2001)